WEBER Olaf,WEBER Olaf,ZIEGELBAUER Karl,ZIEGELBAUER Karl
申请号：
SI201331181
公开号：
SI2900269T1
申请日:
2013.09.23
申请国别(地区):
SI
年份:
2018
代理人:
摘要：
The present invention relates to pharmaceutical compositions and combinations comprising regorafenib and acetylsalicylic acid, or a hydrate, solvate, metabolite or pharmaceutically acceptable salt thereof or a polymorph thereof for treating, preventing or managing diseases and conditions including hyperproliverative disorders such as cancer in humans and other mammals.
